Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NextGen Biomed Ltd. Delisting Announcement 2024

May 1, 2024

6949_rns_2024-05-01_24271682-9783-441a-b2b4-ff9e8445f44c.pdf

Delisting Announcement

Open in viewer

Opens in your device viewer

==> picture [111 x 87] intentionally omitted <==

May 1, 2024 441767.docx

To: TASE Members

Dear Sir/Madam,

Re: NEXTGEN BIOMED LTD

  1. Following our notice dated April 18 ,2024, please note that trading in the company's shares (ISIN no. IL0010839301) has been suspended as of today, May 1, 2024, since the company has not yet submitted its financial reports for 2023.

  2. According to TASE's rules and regulations, where a security is traded on the maintenance list or suspended from trade, the security shall be de-listed from trade if 48 months have passed from the date on which the security ceased to be traded in the framework of the main list, and the conditions for the renewal of trade therein on the main list have not been fulfilled .

Sincerely,

(-)

Listing companies compliance unit

==> picture [385 x 58] intentionally omitted <==